Life Sciences VC Firm Seroba Closes $134M Fund
By Yeji Jesse Lee · February 1, 2024, 6:09 PM EST
Seroba, a European life sciences venture capital firm, said Thursday it has closed a new fund focused on early-stage life sciences companies at €123 million ($134 million)....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login